Table 2 Cross tabulation of the variables according to LNR and positive LN
Characteristics | LNR N (%) | P-value | Positive LN | P-value | ||
|---|---|---|---|---|---|---|
0 – 0.4 | > 0.4 | 1 – 3 | 4+ | |||
Age | 38 (69.1) | 17 (30.9) | 0.743 | 31 (55.4) | 25 (44.6) | 0.32 |
<50 | 25 (78.1) | 7 (21.9) | 17 (53.1) | 15 (46.9) | ||
50 to 60 | 28 (77.8) | 8 (22.2) | 26 (72.2) | 10 (27.8) | ||
61 to 70 | 26 (74.3) | 9 (25.7) | 22 (62.9) | 13 (37.1) | ||
> 71 | ||||||
Stage III | ||||||
IIIA | 12 (100) | 0 (0) | < 0.001 | 13 (100) | 0 (0) | < 0.01 |
IIIB | 95 (88) | 13 (12) | 81 (75) | 27 (25) | ||
IIIC | 10 (26.3) | 28 (73.7) | 2 (5.3) | 36 (94.7) | ||
Adjuvant chemotherapy | ||||||
No | 58 (71.6) | 23 (28.4) | 0.356 | 50 (61.7) | 31 (38.3) | 0.73 |
Yes | 31 (79.5) | 8 (20.5) | 26 (65) | 14 (35) | ||
Gender | ||||||
Female | 65 (80.2) | 16 (19.8) | 0.068 | 44 (57.1) | 33 (42.9) | 0.42 |
Male | 52 (67.5) | 25 (32.5) | 52 (63.4) | 30 (36.6) | ||
LNs resected | ||||||
0 – 11 | 25 (71.4) | 10 (28.6) | 0.688 | 27 (77.1) | 8 (22.9) | 0.02 |
≥ 12 | 92 (74.8) | 31 (25.2) | 68 (55.3) | 55 (44.7) | ||
Grade | ||||||
Well-differentiated | 6 (100) | 0 (0) | 0.002 | 5 (83.3) | 1 (16.7) | 0.21 |
Moderately differentiated | 75 (82.4) | 16 (17.6) | 58 (63) | 34 (37) | ||
Poorly differentiated | 29 (58) | 21 (42) | 26 (52) | 24 (48) | ||
Recurrence | ||||||
No | 23 (76.7) | 7 (23.3) | 0.923 | 16 (53.3) | 14 (46.7) | 0.11 |
Yes | 50 (75.8) | 16 (24.2) | 47 (70.1) | 20 (29.9) | ||